BioXcel Therapeutics inventory hits 52-week low at $0.35 By Investing.com
In a difficult market setting, BioXcel Therapeutics Inc (NASDAQ:). inventory has reached…
Mizuho maintains Impartial ranking on BioXcel shares By Investing.com
Mizuho Securities has reiterated a Impartial ranking on BioXcel Therapeutics (NASDAQ: BTAI),…
